Bringing New Biotech Treatments to Market

Kristen Fortney, BioAge Labs

In conversation with Toby Corey, Stanford University

In Brief

Biotech ventures benefit from starting narrow and broadening over time.

Video clip from Derisking Biotech [Entire Talk] / May 18, 2022

Season 17

Episode 23 of Entrepreneurial Thought Leaders

May 18, 2022

Duration:

2 minutes

Innovation Startups

Download Transcript

BioAge Labs co-founder and CEO Kristen Fortney explains why her company chose to start with finding treatments for diseases that are familiar to regulatory systems and potential payers, while maintaining a broader long-term vision.

Video clips from: Derisking Biotech [Entire Talk]

Opportunities in Aging and Biotech

Watch now

Derisking Milestones in Biotech

Watch now

Bringing New Biotech Treatments to Market

Watch now

Related